PMID: 6409345Aug 1, 1983Paper

Acrosoxacin in the treatment of uncomplicated gonorrhoea

The British Journal of Venereal Diseases
R J WalshR C Slack

Abstract

Acrosoxacin was given as a single 300 mg oral dose to 105 patients with acute gonorrhoea. Of the 100 patients followed completely there was a 93% cure rate and 33% of men developed postgonococcal urethritis (PGU). This compared with a 97% cure and 30% PGU with 2 megaunits penicillin. The in vitro activity of acrosoxacin in Nottingham against strains of Neisseria gonorrhoeae showed that it was a highly active agent with 90% of strains inhibited by a concentration of 0.03 mg/l.

References

Feb 1, 1978·The British Journal of Venereal Diseases·H Young
Apr 1, 1975·The British Journal of Venereal Diseases·M Shahidullah
Feb 1, 1981·The British Journal of Venereal Diseases·C A WarrenI Phillips

❮ Previous
Next ❯

Citations

Apr 1, 1984·Antimicrobial Agents and Chemotherapy·B RomanowskiK B Nguyen
Oct 1, 1984·The British Journal of Venereal Diseases·C A HartD Hobson
Oct 1, 1984·The British Journal of Venereal Diseases·A H Sumathipala
Oct 1, 1984·The British Journal of Venereal Diseases·R J Van RoosbroeckD L Van Caekenberghe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The British Journal of Venereal Diseases
C A WarrenI Phillips
The British Journal of Venereal Diseases
K PanikabutraC Saensanoh
© 2021 Meta ULC. All rights reserved